The global Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ 21200 million in 2024 and is projected to reach US$ 30080 million by 2030, at a CAGR of 5.1% during the forecast period.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Non-Selective NSAIDs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Non-Steroidal Anti-Inflammatory Drugs include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy?s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs. This report contains market size and forecasts of Non-Steroidal Anti-Inflammatory Drugs in global, including the following market information:
Global Non-Steroidal Anti-Inflammatory Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Non-Steroidal Anti-Inflammatory Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Steroidal Anti-Inflammatory Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Non-Steroidal Anti-Inflammatory Drugs Market Segment Percentages, by Type, 2023 (%)
- Non-Selective NSAIDs
- COX-2 Selective NSAIDs
Global Non-Steroidal Anti-Inflammatory Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Non-Steroidal Anti-Inflammatory Drugs Market Segment Percentages, by Application, 2023 (%)
- Dental Pain
- Muscle Aches
- Pain caused by Gout
- Bursitis
- Menstrual Cramps
- Fever
- Others
Global Non-Steroidal Anti-Inflammatory Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Non-Steroidal Anti-Inflammatory Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Non-Steroidal Anti-Inflammatory Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Non-Steroidal Anti-Inflammatory Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc.
- Bayer AG
- GSK plc
- Dr. Reddy?s Laboratories Ltd
- Viatris Inc
- Teva Pharmaceutical Industries Ltd.
- Johnson And Johnson Services, Inc.
- Merck & Co., Inc.
- Including or Excluding key companies relevant to your analysis.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Steroidal Anti-Inflammatory Drugs, market overview.
Chapter 2: Global Non-Steroidal Anti-Inflammatory Drugs market size in revenue.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Steroidal Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-Steroidal Anti-Inflammatory Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Steroidal Anti-Inflammatory Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Steroidal Anti-Inflammatory Drugs Overall Market Size
2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size: 2023 VS 2030
2.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Steroidal Anti-Inflammatory Drugs Players in Global Market
3.2 Top Global Non-Steroidal Anti-Inflammatory Drugs Companies Ranked by Revenue
3.3 Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Companies
3.4 Top 3 and Top 5 Non-Steroidal Anti-Inflammatory Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Non-Steroidal Anti-Inflammatory Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs Players in Global Market
3.6.1 List of Global Tier 1 Non-Steroidal Anti-Inflammatory Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Steroidal Anti-Inflammatory Drugs Market Size Markets, 2023 & 2030
4.1.2 Non-Selective NSAIDs
4.1.3 COX-2 Selective NSAIDs
4.2 By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue & Forecasts
4.2.1 By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2024
4.2.2 By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2025-2030
4.2.3 By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Steroidal Anti-Inflammatory Drugs Market Size, 2023 & 2030
5.1.2 Dental Pain
5.1.3 Muscle Aches
5.1.4 Pain caused by Gout
5.1.5 Bursitis
5.1.6 Menstrual Cramps
5.1.7 Fever
5.1.8 Others
5.2 By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue & Forecasts
5.2.1 By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2024
5.2.2 By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2025-2030
5.2.3 By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Non-Steroidal Anti-Inflammatory Drugs Market Size, 2023 & 2030
6.2 By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue & Forecasts
6.2.1 By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2024
6.2.2 By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2025-2030
6.2.3 By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2030
6.3.2 US Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2030
6.4.2 Germany Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4.3 France Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4.4 U.K. Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4.5 Italy Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4.6 Russia Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.4.8 Benelux Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2030
6.5.2 China Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.5.3 Japan Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.5.4 South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.5.6 India Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2030
6.6.2 Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.6.3 Argentina Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2030
6.7.2 Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.7.3 Israel Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
6.7.5 UAE Non-Steroidal Anti-Inflammatory Drugs Market Size, 2019-2030
7 Non-Steroidal Anti-Inflammatory Drugs Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.1.4 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.2.4 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.2.5 Bayer AG Key News & Latest Developments
7.3 GSK plc
7.3.1 GSK plc Company Summary
7.3.2 GSK plc Business Overview
7.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.3.4 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.3.5 GSK plc Key News & Latest Developments
7.4 Dr. Reddy?s Laboratories Ltd
7.4.1 Dr. Reddy?s Laboratories Ltd Company Summary
7.4.2 Dr. Reddy?s Laboratories Ltd Business Overview
7.4.3 Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.4.4 Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.4.5 Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
7.5 Viatris Inc
7.5.1 Viatris Inc Company Summary
7.5.2 Viatris Inc Business Overview
7.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.5.4 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.5.5 Viatris Inc Key News & Latest Developments
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.6.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.7 Johnson And Johnson Services, Inc.
7.7.1 Johnson And Johnson Services, Inc. Company Summary
7.7.2 Johnson And Johnson Services, Inc. Business Overview
7.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.7.4 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.7.5 Johnson And Johnson Services, Inc. Key News & Latest Developments
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Company Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Major Product Offerings
7.8.4 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue in Global Market (2019-2024)
7.8.5 Merck & Co., Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non-Steroidal Anti-Inflammatory Drugs Market Opportunities & Trends in Global Market
Table 2. Non-Steroidal Anti-Inflammatory Drugs Market Drivers in Global Market
Table 3. Non-Steroidal Anti-Inflammatory Drugs Market Restraints in Global Market
Table 4. Key Players of Non-Steroidal Anti-Inflammatory Drugs in Global Market
Table 5. Top Non-Steroidal Anti-Inflammatory Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Non-Steroidal Anti-Inflammatory Drugs Product Type
Table 9. List of Global Tier 1 Non-Steroidal Anti-Inflammatory Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Non-Steroidal Anti-Inflammatory Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Non-Steroidal Anti-Inflammatory Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Non-Steroidal Anti-Inflammatory Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Non-Steroidal Anti-Inflammatory Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 32. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Bayer AG Company Summary
Table 35. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 36. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Bayer AG Key News & Latest Developments
Table 38. GSK plc Company Summary
Table 39. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 40. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. GSK plc Key News & Latest Developments
Table 42. Dr. Reddy?s Laboratories Ltd Company Summary
Table 43. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 44. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
Table 46. Viatris Inc Company Summary
Table 47. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 48. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Viatris Inc Key News & Latest Developments
Table 50. Teva Pharmaceutical Industries Ltd. Company Summary
Table 51. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 52. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 54. Johnson And Johnson Services, Inc. Company Summary
Table 55. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 56. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Johnson And Johnson Services, Inc. Key News & Latest Developments
Table 58. Merck & Co., Inc. Company Summary
Table 59. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offerings
Table 60. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Merck & Co., Inc. Key News & Latest Developments
List of Figures
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Segment by Type in 2023
Figure 2. Non-Steroidal Anti-Inflammatory Drugs Segment by Application in 2023
Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2023
Figure 8. By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 16. US Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 28. China Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
